215 related articles for article (PubMed ID: 31566112)
41. Clinical, Economic, and Organizational Impact of the Clinical Pharmacist in an Orthopedic and Trauma Surgery Department.
Renaudin P; Coste A; Audurier Y; Berbis J; Canovas F; Jalabert A; Castet-Nicolas A; Mercier G; Villiet M; Dagneaux L; Breuker C
J Patient Saf; 2021 Dec; 17(8):e1507-e1513. PubMed ID: 30365407
[TBL] [Abstract][Full Text] [Related]
42. Impact of clinical pharmacy services in a hematology/oncology ward in Morocco.
Moukafih B; Abahssain H; Mrabti H; Errihani H; Rahali Y; Taoufik J; Chaibi A
J Oncol Pharm Pract; 2021 Mar; 27(2):305-311. PubMed ID: 32326873
[TBL] [Abstract][Full Text] [Related]
43. Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge.
Najafzadeh M; Schnipper JL; Shrank WH; Kymes S; Brennan TA; Choudhry NK
Am J Manag Care; 2016 Oct; 22(10):654-661. PubMed ID: 28557517
[TBL] [Abstract][Full Text] [Related]
44. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of pharmacist clinical interventions in a Dutch hospital setting.
Bosma L; Jansman FG; Franken AM; Harting JW; Van den Bemt PM
Pharm World Sci; 2008 Jan; 30(1):31-8. PubMed ID: 17592752
[TBL] [Abstract][Full Text] [Related]
46. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
[TBL] [Abstract][Full Text] [Related]
47. Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital.
Amir M; Zehra A; Munawar R; Gul W; Fatima T; Khan Y; Jaffery R; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):533-539. PubMed ID: 38362677
[TBL] [Abstract][Full Text] [Related]
48. Economic effects of clinical pharmacy interventions: a literature review.
De Rijdt T; Willems L; Simoens S
Am J Health Syst Pharm; 2008 Jun; 65(12):1161-72. PubMed ID: 18541687
[TBL] [Abstract][Full Text] [Related]
49. Reducing medication errors in critical care patients: pharmacist key resources and relationship with medicines optimisation.
Bourne RS; Shulman R; Jennings JK
Int J Pharm Pract; 2018 Dec; 26(6):534-540. PubMed ID: 29314430
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of Targeted Pharmacist Interventions to Reduce Length of Stay in an Acute Care Practice Model.
Leary MH; Morbitzer K; Walston BJ; Clark S; Kaplan J; Waldron K; Valgus J; Falato C; Amerine L
Ann Pharmacother; 2019 May; 53(5):471-477. PubMed ID: 30449133
[TBL] [Abstract][Full Text] [Related]
51. A cost-effectiveness evaluation of hospital discharge counseling by pharmacists.
Chinthammit C; Armstrong EP; Warholak TL
J Pharm Pract; 2012 Apr; 25(2):201-8. PubMed ID: 21987529
[TBL] [Abstract][Full Text] [Related]
52. Clinical relevance of pharmacist intervention in an emergency department.
Pérez-Moreno MA; Rodríguez-Camacho JM; Calderón-Hernanz B; Comas-Díaz B; Tarradas-Torras J
Emerg Med J; 2017 Aug; 34(8):495-501. PubMed ID: 27920036
[TBL] [Abstract][Full Text] [Related]
53. The impact of a pharmacist on post-take ward round prescribing and medication appropriateness.
Bullock B; Donovan P; Mitchell C; Whitty JA; Coombes I
Int J Clin Pharm; 2019 Feb; 41(1):65-73. PubMed ID: 30610543
[TBL] [Abstract][Full Text] [Related]
54. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
Kuo GM; Touchette DR; Marinac JS
Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
[TBL] [Abstract][Full Text] [Related]
55. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
[TBL] [Abstract][Full Text] [Related]
56. An analysis of pharmacist interventions.
Torchinsky A; Landry D
Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
[TBL] [Abstract][Full Text] [Related]
57. Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital.
Gunterus A; Lopchuk S; Dunn C; Floyd R; Normandin B
Ment Health Clin; 2016 Sep; 6(5):242-247. PubMed ID: 29955477
[TBL] [Abstract][Full Text] [Related]
58. Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis.
Georgieva D; Markley B; DeClercq J; Choi L; Zuckerman AD
J Manag Care Spec Pharm; 2024 Apr; 30(4):336-344. PubMed ID: 38555624
[TBL] [Abstract][Full Text] [Related]
59. Impact of clinical pharmacy services in a short stay unit of a hospital emergency department in Qatar.
Abdelaziz H; Al Anany R; Elmalik A; Saad M; Prabhu K; Al-Tamimi H; Salah SA; Cameron P
Int J Clin Pharm; 2016 Aug; 38(4):776-9. PubMed ID: 27033505
[TBL] [Abstract][Full Text] [Related]
60. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
